Hodgkin Lymphoma News and Research

RSS
Researchers launch clinical trials to test novel cellular-immunotherapy to treat three types of blood cancer

Researchers launch clinical trials to test novel cellular-immunotherapy to treat three types of blood cancer

Higher body weight, taller stature during adolescence increase NHL risk

Higher body weight, taller stature during adolescence increase NHL risk

Young African Americans, Hispanics fare worse when faced with Hodgkin lymphoma

Young African Americans, Hispanics fare worse when faced with Hodgkin lymphoma

African-American pediatric lymphoma patients have inferior outcomes compared to white and Hispanic peers

African-American pediatric lymphoma patients have inferior outcomes compared to white and Hispanic peers

New study finds significant racial disparity in patients with HIV and Hodgkin lymphoma

New study finds significant racial disparity in patients with HIV and Hodgkin lymphoma

New study examines single 'transformer' proteins involved in cancer

New study examines single 'transformer' proteins involved in cancer

Innovative Phase II trial evaluates effectiveness of diabetes medication for lymphoma

Innovative Phase II trial evaluates effectiveness of diabetes medication for lymphoma

New approaches to treating leukemia, lymphoma and myeloma

New approaches to treating leukemia, lymphoma and myeloma

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Many European hospitals fail to routinely test people at risk of HIV infection

Many European hospitals fail to routinely test people at risk of HIV infection

Patients with kidney failure at increased risk of developing different types of cancer

Patients with kidney failure at increased risk of developing different types of cancer

Drug combination produces long-term responses in patients with mantle cell lymphoma

Drug combination produces long-term responses in patients with mantle cell lymphoma

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

Ixazomib’s phase 3 study in relapsed/refractory multiple myeloma presented

Ixazomib’s phase 3 study in relapsed/refractory multiple myeloma presented

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

Bacterium that causes Q fever associated with increased risk of lymphoma

Bacterium that causes Q fever associated with increased risk of lymphoma

EUROCARE 5 study shows large variations in blood cancer patients' survival in Europe

EUROCARE 5 study shows large variations in blood cancer patients' survival in Europe

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Investigational topical drug shows promise in patients with early stage cutaneous T cell lymphoma

Investigational topical drug shows promise in patients with early stage cutaneous T cell lymphoma

Hetero Group launches biosimilar 'Rituximab' under brand name MABALL in India

Hetero Group launches biosimilar 'Rituximab' under brand name MABALL in India